RxDoctor Payments Data

Ayesha Hasan, MD

Advanced Heart Failure and Transplant Cardiology · Columbus, OHNPI 1043266489

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Abbott at 43.0% of the total. 2025 is the largest year on record at $300, 2.3 times the $131 reported in 2019. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in OH, where the typical reported total is $4,421.

$825in general payments, 2019–2025

Across 11 payments — averaging $74.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$355
  • Medtronic$131
  • Abiomed$130
  • Kiniksa Pharmaceuticals, Ltd.$81
  • Teleflex LLC$60
  • Kestra Medical Technology Services, Inc.$51
  • plus $18 from 1 others
$134,616in research payments, 2019–2025

Across 135 payments — averaging $997.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$48K
  • Medtronic$32K
  • ZOLL Respicardia, Inc.$24K
  • Abbott$17K
  • Boston Scientific$14K

What the payments were for

  • Food & beverage$825100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$825 in reported general payments places this provider in the 15th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.

See all advanced heart failure and transplant cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$36,759
Medicare patients
202
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan277$371,469
JardianceEmpagliflozin133$172,254
EliquisApixaban56$85,724
FarxigaDapagliflozin Propanediol23$29,108
XareltoRivaroxaban11$17,932
Sirolimus21$10,397
Tacrolimus17$4,862
Mycophenolate Mofetil43$4,660
Metoprolol Succinate167$3,151
Potassium Chloride83$2,481
VascepaIcosapent Ethyl11$1,824
Spironolactone270$1,550
Eplerenone18$1,531
Torsemide43$1,206
Atorvastatin Calcium124$958

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →